The relationship between oocyst dose and lesion score was evaluated in trials involving five field isolates each of Eimeria acervulina, Eimeria maxima, and Eimeria tenella. Each trial included an uninfected, unmedicated treatment, and at least three treatments of unmedicated birds given different doses of oocysts from a single isolate. In four trials each with E. acervulina and E. tenella, and all five trials with E. maxima, infected, salinomycin-medicated (60 ppm) treatments were included. Each treatment consisted of five cages with eight male broiler birds per cage using a randomized complete block design. The relationship between oocyst dose and lesion score was examined within each coccidial species using the linear model: Y = b 0 + b 1 (log n oocyst dose + 1). The results demonstrated that in unmedicated birds, low oocyst doses caused mean lesion scores up to 2.0, but the numbers required to cause higher mean scores were many times greater. Second, the estimated oocyst dose in salinomycin-medicated birds for any given mean lesion score was substantially more than the corresponding estimate for unmedicated birds. These results indicated that there could be wide differences in levels of oocyst dose between unmedicated and medicated birds that lesion scores failed to measure. If lesion scores are used in trials comparing anticoccidial drugs, an alternative design may be to include three infected, unmedicated treatments each given a different level of inoculum (e.g., low, medium, and high). Medicated treatments, given the highest oocyst dose only, would then be compared to each of the infected, unmedicated treatments.
INTRODUCTION
Many of the methods and procedures used today in the development and comparative testing of anticoccidial drugs for broiler chickens were reviewed extensively at a coccidiosis symposium held in 1969 (Barwick et al., 1970; Gard and Tonkinson, 1970; Johnson and Reid, 1970; Long, 1970; Morehouse and Baron, 1970; Ott, 1970; Shumard and Callender, 1970; Waletzky, 1970) . Recommendations by these workers included a standardization of trial procedures, improvements in trial design with adequate replication of cages or pens in each treatment, and the selection of appropriate response variables. There appeared to be general agreement that bird performance, in particular weight gain, was the most sensitive and informative measure of anticoccidial efficacy, with some debate over the usefulness of other variables such as lesion and dropping scores. In the ensuing years, coccidial lesion scores, in particular the procedure described by Johnson and Reid (1970) , assumed an important role as a measure of anticoccidial efficacy.
Experience has shown, however, that lesion scores do not increase linearly with oocyst dose, and that low levels of inocula may produce fairly high lesion scores (McKenzie et al., 1989a,b,c; Conway et al., 1993) . Although this may not be critical if the efficacy of the anticoccidial being tested is ≥ 98%, it can easily result in misleading conclusions if the efficacy falls in a range between 75 and 95%.
If lesion scores are to be used as a response variable to measure anticoccidial efficacy, then more information is needed on the relationship between the level of coccidial challenge and lesion scores. The trials reported here were designed to measure this relationship using monospecific isolates of Eimeria acervulina, Eimeria maxima, and Eimeria tenella inoculated at different levels of challenge in unmedicated and salinomycin-medicated birds.
Levels of Inocula
Dilutions of inocula were prepared to give various doses of E. acervulina (10 3 to 10 6 ), E. maxima (10 2 to 2 × 10 5 ), or E. tenella (5 × 10 2 to 3 × 10 5 ), and were based on the number of sporulated oocysts counted using a hemocytometer counting chamber for each culture. Birds were individually inoculated via the crop with 1 mL of oocyst suspension 24 h after initiation of each test. Uninfected birds were sham inoculated with 1 mL of water.
Experiment Design
Six trials were conducted with E. acervulina (one isolate was used in two trials), and five trials each with E. maxima, and E. tenella. Each trial included an uninfected, unmedicated treatment (UIUM), and at least three treatments of unmedicated birds given different doses of oocysts. In four trials each with E. acervulina and E. tenella, and all five trials with E. maxima, infected, salinomycin 2 -medicated (60 ppm) treatments were included. Birds in the medicated treatments were given different doses of oocysts of the same culture as that given the unmedicated chickens.
At the start of each trial, healthy, male chicks were individually weighed and those weighing within 1 SD of the mean were selected for a trial. Groups of eight birds were selected at random and confined to each cage in the battery unit. Treatments were allotted to five cages each using a randomized complete block design. Each trial was terminated on Day 5 (E. acervulina) or Day 6 (E. maxima and E. tenella) postinoculation. A corn-soybean broiler starter ration (22% protein) was used as the basal ration in all trials.
Statistical Analysis and Model Development
At the termination of each trial, birds were individually weighed and then killed by cervical dislocation. The intestinal tract of each bird was carefully examined externally and internally, and coccidial lesion scores were assigned according to the method described by Johnson and Reid (1970) and illustrated in Conway and McKenzie (1991) . In trials involving E. tenella, both cecal pouches were examined. This procedure was strictly followed by the individuals who participated in the scoring. Generally, microscopic examination was not conducted unless there was a question about the specific nature of a lesion. Weight gain was calculated as the mean final weight of live birds in a pen minus the mean initial weight of all birds for a given treatment.
Within each coccidial species, lesion scores for each treatment were analyzed as a function of the oocyst dose given using linear and nonlinear models (Fryer, 1966; Snedecor and Cochran, 1980) . The model ultimately selected based on the R 2 statistic was the linear model Y = b 0 + b 1 (log n oocyst dose + 1), where Y = lesion score; b 0 = intercept; and b 1 = linear relationship × (log n oocyst dose + 1).
RESULTS

Eimeria acervulina
Least squares means for weight gain and lesion score for each oocyst dose treatment in unmedicated and medicated birds are summarized in Table 1 . Weight gains in unmedicated birds were either not depressed at all or just slightly depressed (≤ 14 g) at a dose rate of 10 4 oocysts per bird in comparison with UIUM birds, but at a dose rate of 10 5 and 10 6 oocysts per bird, gains were depressed by 10 to 60 g and 49 to 102 g, respectively. In salinomycinmedicated birds, all isolates appeared to be sensitive to salinomycin based on the results in Table 1 . Weight gains of birds inoculated with 10 5 oocysts per bird ranged from 2 to 5 g less than those of the UIUM birds, and at 10 6 oocysts per bird, gains were depressed by 7 to 29 g. Lesion scores in unmedicated birds analyzed as a function of the oocyst dose are shown in Figure 1 . The parameters of this relationship were: estimated lesion score (Y) = -0.591 + 0.259 × (log n of the challenge dose + 1). The upper and lower bounds (95% confidence intervals) show a fairly wide range in oocyst dose (R 2 = 0.80). Much of this variance is probably due to differences in pathogenicity between isolates used in this series of trials, but some of it probably relates to the model itself.
Lesion scores as a function of oocyst dose in salinomycin-medicated birds are shown in Figure 2 . The parameters of this relationship were: Y = -0.286 + 0.114 × (log n of the challenge dose + 1). The wider band between the upper and lower bounds indicates a much greater variance (R 2 = 0.57) in this model than in the model for unmedicated birds.
Eimeria maxima
Least squares means for weight gain and lesion score for each oocyst dose treatment in unmedicated and medicated birds are summarized in Table 2 . In unmedicated birds, weight gain means were depressed by 27 to 70 g at 10 4 oocysts per bird and 69 to 80 g at 10 5 and 2 × 10 5 oocysts per bird in comparison with UIUM birds. Weight gain means in medicated birds ranged from 6 to 18 g less than UIUM birds at 10 4 oocysts per bird, and at 10 5 and 2 × 10 5 oocysts per bird weight gains were 8 to 23 g less. Based on these data, all isolates appeared to be sensitive to salinomycin.
Lesion scores in unmedicated and salinomycinmedicated birds as a function of E. maxima oocyst dose are shown in Figures 3 and 4 , respectively. The parameters of the relationship for unmedicated birds were: estimated lesion score (Y) = 0.063 + 0.251 × (log n of the challenge dose + 1). The fairly narrow upper and lower bounds indicated much of the variance was accounted for in this model (R 2 = 0.85). The parameters of the relationship for medicated birds were: estimated lesion score (Y) = 0.010 + 0.109 × (log n of the challenge dose + 1). Again, the relatively narrow upper and lower bounds indicated that much of the variance was accounted for in the model (R 2 = 0.84). 
Eimeria tenella
Least squares means for weight gain and lesion score for each oocyst dose treatment in unmedicated and medicated birds are summarized in Table 3 . Weight gain means in unmedicated birds were not affected or were mildly depressed (≤ 18 g) at inocula levels up to 5 × 10 3 oocysts per bird in comparison with UIUM birds, and were more severely affected (40 to 76 g) at inocula levels in the range of 5 × 10 4 to 2 × 10 5 oocysts per bird. One exception to this was isolate 87TX011TE03, which was only mildly pathogenic at the highest level (5 × 10 4 oocysts per bird) tested. In salinomycin-medicated birds, weight gains were only mildly affected at dose levels of 10 4 and 10 5 oocysts per bird in comparison with the UIUM birds except in the test with isolate 87DA010TE02. The results with the latter isolate indicated a reduced sensitivity to salinomycin.
Lesion scores in unmedicated and salinomycinmedicated birds as a function of different E. tenella oocyst doses are shown in Figures 5 and 6 , respectively. Parameters for the relationship in unmedicated birds were: estimated lesion score (Y) = -0.611 + 0.274 × (log n of the challenge dose + 1). The upper and lower bounds indicate that much of the variance was accounted for by the model (R 2 = 0.86). Parameters for the relationship in salinomycin-medicated birds were: estimated lesion score (Y) = -0.551 + 0.176 × (log n of the challenge dose + 1). The wider 95% confidence limits, particularly at the lower and higher ranges of oocyst doses, indicated a greater degree of variance in this model (R 2 = 0.63) than in the model for unmedicated birds.
DISCUSSION
Using the models shown in Figures 1 to 6 , the estimated oocyst dose for a range of lesion scores for each species are given in Table 4 . The oocyst dose estimates have been converted from the transformed 1 Estimated oocyst dose = e (lesion score + 0.5910) ÷ 0.2590 for E. acervulina, = e (lesion score -0.0633) ÷ 0.2511 for E. maxima, = e (lesions score + 0.6111) ÷ 0.2737 for E. tenella.
2 Note: Models in Footnotes 1 and 3 were derived from the parameters for the relationship between lesion score as a function of oocyst dose for each species in unmedicated and medicated birds. The oocyst dose estimates given in the table have been converted from the transformed log n + 1 estimate obtained from each model after solving for a given lesion score.
3 Estimated oocyst dose = e (lesion score + 0.2857) ÷ 0.1143 for E. acervulina, = e (lesion score -0.0097) ÷ 0.1093 for E. maxima, = e (lesions score + 0.5512) ÷ 0.1758 for E. tenella. 4 Due to a limitation in the model for medicated birds, it was not possible to estimate the oocyst dose in this instance. Table 4 demonstrated two factors that should be considered if lesion scores are to be used as an indicator of the level of coccidial infection in chickens. First, in unmedicated birds, relatively low oocyst doses can result in mean lesion scores up to 2.0. This result was especially noteworthy in the work with E. maxima, for which the model estimated an oocyst dose of 2,239 oocysts per bird to give a mean lesion score of 2.0 (Table  4) . Another way of looking at this effect is that for both unmedicated and medicated birds there were greater lesion scores per oocyst input for scores in the lower half of the scoring range than for higher mean scores. Second, the estimated oocyst dose in salinomycinmedicated birds for any given mean lesion score was many times greater than the corresponding estimate for unmedicated birds. This medication effect is attributed to the efficacy of salinomycin and is reflected in the differences in the slopes of the relationship in medicated and unmedicated birds for each Eimeria species. The difference between unmedicated and medicated birds in the estimated oocyst dose for a given mean lesion score as summarized in Table 4 , for example, is an estimate of the efficacy of salinomycin.
A number of workers have shown that significant differences in weight gain may be demonstrated in groups of birds with the same or comparable lesion scores depending on whether they were immunized or nonimmunized, or medicated or unmedicated (Long et al., 1980; Bafundo and Donovan, 1988; Conway et al., 1990; Augustine et al., 1991 Augustine et al., , 1993 . The models presented here certainly give further support to the hypothesis that the significant improvements in weight gain observed by the above workers were due to reduced levels of infection in the immunized or medicated birds that lesion scores failed to measure.
One way to circumvent this dilemma would be to include in each study three infected, unmedicated treatments, each inoculated with a different level of oocysts (e.g., low, medium, and high) to compare with the medicated treatments inoculated at the highest dose only. Development of a protocol to include three unmedicated treatments as suggested would establish a dose response curve (or standard) in unmedicated birds of the effects of different levels of oocyst challenge on lesion scores, and any other response variable being considered. Differences due to isolate pathogenicity, species mix, and the efficacy of the anticoccidials being tested could then be taken into account with improved efficiency and precision (Conway et al., 1995) .
Finally, under present conditions in the field in which the efficacy of many anticoccidials in terms of lesion control is often less than 98%, it may be time to revise the way we measure anticoccidial efficacy. Perhaps more consideration should be given to placing much greater emphasis on objective measures such as weight gain, feed consumption, and feed conversion.
